India: No New COVID-19 Cases in 61 Districts, Significant Rise Unlikely



The ICMR (Indian Council of Medical Research) said that the present situation of Coronavirus in India indicates that a significant increase in the number of positive cases is unlikely.

Responding to a query at the daily briefing, Dr. Raman Gangakhedkar, head of infectious disease and epidemiology at ICMR, said: “The doubling time of cases is increasing, the current situation indicates that significant increase in number of Covid-19 cases is unlikely.”

The Health Ministry said that four districts- Mahe (Puducherry), Kodagu (Karnataka), Pauri Garhwal (Uttrakhand) and Pratapgarh (Rajasthan) have not reported any fresh cases during the last 28 days. “There are now 61 additional districts from 23 States/UT that have not reported any fresh cases during the last 14 Days. Four new districts have been included in the list — Latur, Osmanabad, Hingoli & Washim from Maharashtra,” it said.

Joint Secretary, Health, Lav Agarwal, responding to a media query, said there are few reports of lab-confirmed Covid-19 cases which are truly asymptomatic. “There has been no documented asymptomatic transmission. This does not exclude the possibility that it may occur. Among the total Covid-19 tests conducted so far, 69 per cent were asymptomatic cases and 31 per cent were symptomatic cases,” he said.

The Health Ministry added that using community surveillance and contact tracing, it is taking pre-emptive action to test asymptomatic persons with high risk contacts. This helps to identify Covid-19 patients at an early stage to treat them and reduce mortality, it added.

It also said that Council of Scientific and Industrial Research (CSIR) is launching a randomised, blinded, two arms, active comparator-controlled clinical trial to evaluate drug efficacy to reduce mortality in critically-ill Covid-19 patients. “Given the similarities between the clinical characteristics of patients suffering from Covid-19 and Gram-negative sepsis, the Drugs Controller General of India (DCGI) has approved the trial and it will soon begin in multiple hospitals,” said Agarwal.

Previous articleDutch court approves euthanasia in advanced dementia cases
Next articleWhat is VPN? Why Would you use them
Arushi Sana is the Founder of Santerra Living and Co-Founder of NYK Daily. She was awarded the Times Power Women of the Year 2022 and Times Digital Entrepreneur of the Year 2023. Arushi is also a Sustainability Consultant for organisations looking to reduce their carbon footprint and also works with brands on social media to help them carve a presence in that niche. She holds a Degree in Computer Science Engineering from VIT University and a Diploma in Marketing Analytics from IIM Nagpur. Her interest in Sustainable Living and Interior Design led her to start a Sustainable e-Marketplace where customers can buy eco-furniture and eco-friendly products for everyday use. Arushi is a writer, political researcher, a social worker, a farmer and a singer with an interest in languages. Travel and nature are the biggest spiritual getaways for her, and she aims to develop a global community of knowledge and journalism par excellence through this News Platform.

Was it worth reading? Let us know.